Nitika Sharma, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 Celebrate Life Pkwy, Newnan, GA 30265 Phone: 770-400-6000 |
Dr. Bamidele A Adesunloye, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 Celebrate Life Pkwy, Newnan, GA 30265 Phone: 770-400-6000 |
Minesh D Patel, MD Internal Medicine - Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 775 Poplar Rd Ste 310, Newnan, GA 30265 Phone: 770-251-2590 Fax: 770-251-1490 |
Dr. Vasileios John Assikis, M.D. Internal Medicine - Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 775 Poplar Rd Ste 310, Newnan, GA 30265 Phone: 770-251-2590 Fax: 770-251-1490 |
News Archive
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
ReachMD, the nation's fastest growing media communications provider for medical professionals, will broadcast a special report on the health impacts of the Haiti earthquake with specific focus on the medical response throughout the week of January 25, 2010. The special program was recorded on Wednesday, January 20th and can be previewed here – http://www.ReachMD.com/haiti.
With scientific evidence now supporting the age-old wisdom that cranberries, whether in sauce or as juice, prevent urinary tract infections, people have wondered if there was an element of the berry that, if extracted and condensed, perhaps in pill form, would be as effective as drinking the juice or eating cranberry sauce. A new study from researchers at Worcester Polytechnic Institute helps to answer that question.
An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the risk of glaucoma
The recalled Sprint Fidelis implantable cardioverter-defibrillator leads failed more often in younger patients, women, and individuals with hereditary heart disease, according to a multicenter study published online Jan. 17 in Circulation. The researchers found that lead failure was not associated with death or serious injuries.
› Verified 1 days ago